Antibiotics are medicines that act against susceptible bacteria and are used to prevent or treat selected bacterial infections. The term is often used broadly for antibacterial medicines, although historically antibiotic referred more specifically to substances produced by microorganisms that inhibit other microorganisms; modern usage generally includes many naturally derived, semi-synthetic and synthetic antibacterial agents. Antibiotics do not directly treat viral infections because viruses lack the bacterial cellular structures or metabolic processes targeted by most antibacterial medicines. Appropriate antibiotic selection depends on the suspected or confirmed organism, infection site, severity, resistance pattern, patient characteristics and pharmacological properties of the medicine.
Antibiotics act through several major antibacterial mechanisms. Some interfere with bacterial cell-wall synthesis, others inhibit protein production, disrupt nucleic-acid processes, interfere with metabolic pathways or damage bacterial membranes. These mechanisms exploit differences between bacterial cells and human cells, although selectivity is not absolute and adverse effects can occur. Different medicines have different spectra of activity, meaning they are effective against different groups of bacteria. Broad-spectrum activity can be useful when the causative organism is uncertain, but unnecessarily broad treatment can increase selection pressure for resistance and may disturb normal microbial communities.
Diagnosis is central to appropriate Antibiotics use because not every infection is bacterial and not every bacterial infection requires the same medicine. Clinical assessment may be supplemented by microscopy, culture, molecular testing or other laboratory methods that identify pathogens or resistance characteristics. Empirical treatment may begin before definitive results when delay would create significant risk, after which therapy can sometimes be narrowed or changed according to microbiological evidence and clinical response. The infection site matters because a medicine must reach effective concentrations in the relevant tissue. Factors such as abscess formation, foreign material and impaired blood supply can also influence treatment effectiveness.
Antibiotic resistance occurs when bacteria acquire or develop characteristics that allow them to survive exposure to medicines that would previously have inhibited or killed them. Resistance can arise through mutation and through acquisition of genetic material from other bacteria. Antibiotic exposure creates selection pressure under which resistant organisms can become more prevalent. Resistance is therefore a biological phenomenon rather than evidence that an individual person has become resistant. Infections caused by resistant bacteria can be more difficult to treat and may require medicines with greater toxicity, more complicated administration or limited availability.
Appropriate duration of Antibiotics treatment depends on the infection and evidence supporting the particular regimen. Longer treatment is not automatically better because unnecessary exposure can increase adverse effects and selection for resistant organisms. Conversely, stopping a prescribed course prematurely may be inappropriate for some infections and can contribute to treatment failure depending on the condition and regimen. Modern antimicrobial stewardship focuses on using antibiotics only when indicated and selecting the narrowest suitable treatment, dose and duration supported by clinical evidence. The correct regimen is therefore condition-specific rather than governed by one universal duration rule.
Antibiotics can cause adverse effects ranging from gastrointestinal symptoms and skin reactions to severe organ-specific or immune-mediated reactions. They can also disrupt normal microbial communities, allowing certain opportunistic organisms to proliferate. Drug interactions can occur through pharmacokinetic or pharmacodynamic mechanisms, and individual medicines differ substantially in their interaction profiles. Allergies must be distinguished from predictable non-allergic adverse effects because the management and implications differ. A reported antibiotic allergy should be assessed appropriately where possible because inaccurate allergy labels can unnecessarily restrict future treatment choices and influence prescribing.
Antibiotics are also used in selected preventive circumstances, such as particular surgical procedures or exposure-related situations, but prophylactic use should have a defined clinical rationale. Routine use for uncomplicated viral respiratory illnesses is inappropriate because antibacterial activity does not eliminate viruses. Unnecessary use exposes individuals to adverse effects without providing the intended benefit and contributes to antimicrobial resistance at population level. Public-health stewardship therefore considers both the immediate patient and the broader consequences of unnecessary antibacterial exposure.
A common misconception is that Antibiotics are general-purpose medicines for any infection or that they speed recovery from every fever, cough or sore throat. Their effectiveness depends on the presence of susceptible bacteria and adequate exposure at the infection site. Another misconception is that antibiotic resistance means the patient's body becomes resistant; resistance belongs to bacteria and can spread between organisms. Safe antibiotic use requires accurate diagnosis where possible, appropriate medicine selection, correct dosing, attention to allergies and interactions, and avoidance of unnecessary treatment.
